Trade Summary

3 days ago, Stueland Katherine, serving as CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. (WGS), sold 10,501 shares at $60.77 per share, for a total transaction value of $638,104.42. Following this transaction, Stueland Katherine now holds 104,372 shares of WGS.

This sale represents a 9.14% decrease in Stueland Katherine's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 16, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 18, 2026 at 4:09 PM ET, 2 days after the trade was made.

GeneDx Holdings Corp. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.